Study Stopped
From June 08, 2024, the study device was no longer marketed in France. Therefore, the sponsor decided to terminate the study prematurely.
Real-Life Use of Transabdominal Restorelle® Meshes in Apical Prolapse Repair
REPAIR
1 other identifier
observational
39
1 country
6
Brief Summary
The purpose of this study is to prospectively follow patients after a sacrocolpopexy with Restorelle® mesh for apical prolapse repair as part of routine care. It will help to describe the safety profile and to confirm the clinical benefits of Restorelle mesh for at least 5 to 8 years post-surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2023
Shorter than P25 for all trials
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 21, 2023
CompletedFirst Submitted
Initial submission to the registry
November 24, 2023
CompletedFirst Posted
Study publicly available on registry
March 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 6, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 6, 2024
CompletedJanuary 28, 2026
January 1, 2026
12 months
November 24, 2023
January 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The incidence rate of a surgical reintervention related to Restorelle mesh use over at least the 5 first years of post-index procedure follow-up
up to 5 years
Secondary Outcomes (24)
Incidence rate of surgical reintervention related to Restorelle mesh use in patients
through study completion, at least 5 and up to 8 years
Number of patients who have only had surgical reintervention not related to Restorelle mesh use
through study completion, at least 5 and up to 8 years
Percentage of patients who have only had surgical reintervention not related to Restorelle mesh use
through study completion, at least 5 and up to 8 years
Number of patients who have had more than 1 surgical reintervention (unrelated to mesh use)
5 years ; up to 8-year after index procedure
Percentage of patients who have had more than 1 surgical reintervention (unrelated to mesh use)
5 years ; up to 8-year after index procedure
- +19 more secondary outcomes
Interventions
The Coloplast Restorelle® Polypropylene Mesh is a Class III, implantable, permanent, non-absorbable, single use device indicated to restore female pelvic floor anatomy by providing anatomical support and suspension as a bridging material to support deficient fascia that resulted in descent of the female pelvic organs (pelvic organ prolapse). Restorelle mesh is a synthetic, macroporous mesh constructed of medical grade knitted, monofilament polypropylene.
Eligibility Criteria
Adult female patients presenting with apical pelvic organ prolapse which is clinically indicated for a surgical treatment with Restorelle mesh
You may qualify if:
- Female patient of at least 18 years old
- Patient presenting apical pelvic organ prolapse and being eligible to surgical treatment
- Patient having received appropriate information and counselling before mesh implantation
- Patient has been provided written informed consent
You may not qualify if:
- Patient currently pregnant or breastfeeding
- Patient being deprived of liberty by a judicial or administrative decision, or who is under a measure of legal protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Coloplast A/Slead
- International Clinical Trials Associationcollaborator
Study Sites (6)
Polyclinique de la Baie
Avranches, Choisir Une Région, 50300, France
CHU Pellegrin
Bordeaux, 33076, France
CH La Rochelle
La Rochelle, 17019, France
Clinique Bon Secours
Le Puy-en-Velay, 43000, France
Institut Mutualiste Montsouris
Paris, 75014, France
CH de Saintonge
Saintes, 17108, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philippe Ferry, Dr
CH La Rochelle, France
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 24, 2023
First Posted
March 6, 2024
Study Start
November 21, 2023
Primary Completion
November 6, 2024
Study Completion
November 6, 2024
Last Updated
January 28, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
There is not a plan to make IPD available